Search details
1.
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
Oncology
; 99(8): 518-527, 2021.
Article
in English
| MEDLINE | ID: mdl-33906189
2.
AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy.
BMC Cancer
; 21(1): 699, 2021 Jun 14.
Article
in English
| MEDLINE | ID: mdl-34126947
3.
Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study.
BMC Gastroenterol
; 21(1): 489, 2021 Dec 20.
Article
in English
| MEDLINE | ID: mdl-34930140
4.
Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Hepatol Res
; 51(8): 880-889, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33837620
5.
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
J Gastroenterol Hepatol
; 36(7): 1812-1819, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33171524
6.
Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.
J Med Virol
; 92(12): 3507-3515, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32374470
7.
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
Oncology
; 98(5): 295-302, 2020.
Article
in English
| MEDLINE | ID: mdl-32097925
8.
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 40(4): 968-976, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32064740
9.
SARC-F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease.
Hepatol Res
; 50(4): 502-511, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31830344
10.
Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virus.
Hepatol Res
; 50(1): 92-100, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31729124
11.
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Hepatol Res
; 50(1): 75-83, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31660700
12.
Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
J Gastroenterol Hepatol
; 35(2): 299-304, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31318996
13.
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.
J Gastroenterol Hepatol
; 35(8): 1420-1425, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-31950525
14.
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
J Gastroenterol Hepatol
; 35(7): 1229-1237, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-31881554
15.
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
J Gastroenterol Hepatol
; 35(5): 855-861, 2020 May.
Article
in English
| MEDLINE | ID: mdl-31609495
16.
[A case of mass-forming chronic pancreatitis with amputation neuroma-like neurogenesis of the bile duct].
Nihon Shokakibyo Gakkai Zasshi
; 117(3): 261-269, 2020.
Article
in Japanese
| MEDLINE | ID: mdl-32161248
17.
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.
Oncology
; 97(6): 334-340, 2019.
Article
in English
| MEDLINE | ID: mdl-31466068
18.
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.
Oncology
; 97(5): 277-285, 2019.
Article
in English
| MEDLINE | ID: mdl-31307035
19.
Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.
Oncology
; 96(5): 242-251, 2019.
Article
in English
| MEDLINE | ID: mdl-30893698
20.
Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection.
Hepatol Res
; 49(2): 136-146, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30335208